ECEESPE2025 ePoster Presentations Metabolism, Nutrition and Obesity (164 abstracts)
Evaluation of patients undergoing bariatric surgery: our experience
Óliver Quintero Rodríguez 1 , Selena Rodriguez Fernandez 1 , Kevin David Díaz Gorrín 1 , Javier Panizo Fra 1 , Ana Paola León Ocando 1 , Laura Mesa Suárez 1 , Elena Rodríguez Sosa 1 , Patricia León González 1 , Macarena Sánchez-Gallego Alonso 1 & Patricia Cabrera García 1
1Hospital Universitario de Canarias, Endocrinology and Nutrition, San Cristóbal de La Laguna, Spain
JOINT3400
Introduction: According to the World Health Organization (WHO), obesity is considered the pandemic of the 21st century. Currently, 1 in 7 people worldwide suffer from obesity, and according to the 2023 World Obesity Atlas, it is projected to affect 1 in 4 people by 2035.
Objectives: To describe the characteristics of patients with obesity who underwent bariatric surgery and attended Nutrition consultations at the Hospital Universitario de Canarias during June, July, and August 2024.
Materials and Methods: A descriptive observational study was conducted on a sample of 138 patients with obesity who underwent bariatric surgery and were evaluated by the Endocrinology and Nutrition Department at the Hospital Universitario de Canarias between June and August 2024. The variables analyzed included sex, weight one year after surgery, maximum body mass index (BMI), comorbidities such as hypertension (HTN), type 2 diabetes mellitus (T2DM), obstructive sleep apnea syndrome (OSAS), percentage of total weight loss, type of surgery performed, and remission of comorbidities.
Results: A total of 138 patients were studied, of whom 111 (80.4%) were women and 27 (19.6%) were men. The median maximum weight was 133 kg, with a mean maximum BMI of 49.89 kg/m2. Among the comorbidities, 51.4% had hypertension, 66.7% had T2DM, and 17.4% had OSAS. The most commonly performed surgery was gastric bypass (71%), followed by sleeve gastrectomy (18.8%) and Scopinaro procedure (5.1%), while newer techniques such as SADI-S (2.9%) were less frequently used. A total weight loss of 36.88% was observed one year after surgery. Regarding T2DM remission, 26.1% of patients achieved full remission, 65.2% showed improvement, and 8% had no changes, with an 18% reduction in HbA1c levels compared to baseline values.
Conclusions: Bariatric surgery remains a therapeutic option for patients with severe obesity who are unable to achieve weight reduction through lifestyle modifications and/or pharmacological treatment. The significant weight loss observed is directly associated with improvement in comorbidities and plays a crucial role in preventing future diseases.
Volume 110
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more